Skip to main content
Clinical Trials/JPRN-UMIN000004422
JPRN-UMIN000004422
Completed
Phase 1

Preoperative chemoradiation therapy combined with peptide vaccination for T3-pancreatic cancer: prospective phase I/II study - Preoperative multimodal treatment for pancreatic cancer

Department of Gastroenterological Surgery, Osaka Medical Center for cancer & Cardiovascular Diseases0 sites50 target enrollmentOctober 20, 2010

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
T3(UICC)-pancreatic cancer
Sponsor
Department of Gastroenterological Surgery, Osaka Medical Center for cancer & Cardiovascular Diseases
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 20, 2010
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Gastroenterological Surgery, Osaka Medical Center for cancer & Cardiovascular Diseases

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Liver, renal dysfunction, severe coronary disease. Unresectable pancreatic cancer, including borderline resectable cases.

Outcomes

Primary Outcomes

Not specified

Similar Trials